Advanced papillary thyroid carcinoma responding to nivolumab.
Miguel Michel OcampoJaren LernerShawnt TosonianConstantin A DasanuPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
To our knowledge, this is the first case report showing the efficacy of nivolumab in the treatment of metastatic papillary thyroid carcinoma. Further studies with immune checkpoint inhibitors in papillary thyroid carcinoma seem warranted.